Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

9 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Novel risk scoring system for metastatic renal cell carcinoma patients treated with cabozantinib.
Martini DJ, Kline MR, Liu Y, Shabto JM, Carthon BC, Russler GA, Yantorni L, Hitron EE, Caulfield S, Goldman JM, Harris WB, Kucuk O, Master VA, Bilen MA. Martini DJ, et al. Among authors: hitron ee. Cancer Treat Res Commun. 2021;28:100393. doi: 10.1016/j.ctarc.2021.100393. Epub 2021 May 9. Cancer Treat Res Commun. 2021. PMID: 34029879 Free PMC article.
Novel risk group stratification for metastatic urothelial cancer patients treated with immune checkpoint inhibitors.
Shabto JM, Martini DJ, Liu Y, Ravindranathan D, Brown J, Hitron EE, Russler GA, Caulfield S, Kissick H, Alemozaffar M, Ogan K, Harris WB, Master VA, Kucuk O, Carthon BC, Bilen MA. Shabto JM, et al. Among authors: hitron ee. Cancer Med. 2020 Apr;9(8):2752-2760. doi: 10.1002/cam4.2932. Epub 2020 Feb 25. Cancer Med. 2020. PMID: 32100417 Free PMC article.
[No title available]
[No authors listed] [No authors listed] PMID: 31806780
Baseline Modified Glasgow Prognostic Score Associated with Survival in Metastatic Urothelial Carcinoma Treated with Immune Checkpoint Inhibitors.
Brown JT, Liu Y, Shabto JM, Martini DJ, Ravindranathan D, Hitron EE, Russler GA, Caulfield S, Yantorni LB, Joshi SS, Kissick H, Ogan K, Harris WB, Carthon BC, Kucuk O, Master VA, Bilen MA. Brown JT, et al. Among authors: hitron ee. Oncologist. 2021 May;26(5):397-405. doi: 10.1002/onco.13727. Epub 2021 Mar 18. Oncologist. 2021. PMID: 33634507 Free PMC article.
Modified Glasgow Prognostic Score associated with survival in metastatic renal cell carcinoma treated with immune checkpoint inhibitors.
Brown JT, Liu Y, Shabto JM, Martini D, Ravindranathan D, Hitron EE, Russler GA, Caulfield S, Yantorni L, Joshi SS, Kissick H, Ogan K, Nazha B, Carthon BC, Kucuk O, Harris WB, Master VA, Bilen MA. Brown JT, et al. Among authors: hitron ee. J Immunother Cancer. 2021 Jul;9(7):e002851. doi: 10.1136/jitc-2021-002851. J Immunother Cancer. 2021. PMID: 34326170 Free PMC article.
Combination Immune Checkpoint Blockade Regimens for Previously Untreated Metastatic Renal Cell Carcinoma: The Winship Cancer Institute of Emory University Experience.
Martini DJ, Olsen TA, Goyal S, Liu Y, Evans ST, Hitron EE, Russler GA, Yantorni L, Caulfield S, Brown JT, Goldman JM, Nazha B, Carthon BC, Harris WB, Kucuk O, Master VA, Bilen MA. Martini DJ, et al. Among authors: hitron ee. J Immunother Precis Oncol. 2022 Jun 14;5(3):52-57. doi: 10.36401/JIPO-22-2. eCollection 2022 Aug. J Immunother Precis Oncol. 2022. PMID: 36034580 Free PMC article.